CN103130876B - 一种高纯度多粘菌素b的制备方法 - Google Patents
一种高纯度多粘菌素b的制备方法 Download PDFInfo
- Publication number
- CN103130876B CN103130876B CN201110390624.5A CN201110390624A CN103130876B CN 103130876 B CN103130876 B CN 103130876B CN 201110390624 A CN201110390624 A CN 201110390624A CN 103130876 B CN103130876 B CN 103130876B
- Authority
- CN
- China
- Prior art keywords
- polymyxin
- purity
- organic solvent
- monomer
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title claims abstract description 14
- 108010093965 Polymyxin B Proteins 0.000 title abstract description 11
- 229920000024 polymyxin B Polymers 0.000 title abstract 5
- 229960005266 polymyxin b Drugs 0.000 title abstract 5
- 238000002360 preparation method Methods 0.000 claims abstract description 22
- 239000012535 impurity Substances 0.000 claims abstract description 12
- 239000000203 mixture Substances 0.000 claims abstract description 12
- 239000003960 organic solvent Substances 0.000 claims abstract description 10
- 238000010612 desalination reaction Methods 0.000 claims abstract description 7
- 239000000243 solution Substances 0.000 claims description 31
- 108700018363 polymyxin B(1) Proteins 0.000 claims description 29
- WQVJHHACXVLGBL-GOVYWFKWSA-N polymyxin B1 Polymers N1C(=O)[C@H](CCN)NC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)CCCC[C@H](C)CC)CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1CC1=CC=CC=C1 WQVJHHACXVLGBL-GOVYWFKWSA-N 0.000 claims description 29
- 108010089148 polymyxin B2 Proteins 0.000 claims description 26
- SGPYLFWAQBAXCZ-RUDZPDEXSA-N polymyxin B2 Polymers N1C(=O)[C@H](CCN)NC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)CCCCC(C)C)CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1CC1=CC=CC=C1 SGPYLFWAQBAXCZ-RUDZPDEXSA-N 0.000 claims description 26
- 239000007788 liquid Substances 0.000 claims description 18
- 239000000178 monomer Substances 0.000 claims description 18
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 15
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 12
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 12
- 239000000872 buffer Substances 0.000 claims description 12
- LVQOKPYWSBORCX-UHFFFAOYSA-L disodium phosphoric acid sulfate Chemical compound S(=O)(=O)([O-])[O-].[Na+].P(O)(O)(O)=O.[Na+] LVQOKPYWSBORCX-UHFFFAOYSA-L 0.000 claims description 12
- 239000002994 raw material Substances 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 8
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 8
- 238000001514 detection method Methods 0.000 claims description 8
- 239000000945 filler Substances 0.000 claims description 8
- LCPVQAHEFVXVKT-UHFFFAOYSA-N 2-(2,4-difluorophenoxy)pyridin-3-amine Chemical compound NC1=CC=CN=C1OC1=CC=C(F)C=C1F LCPVQAHEFVXVKT-UHFFFAOYSA-N 0.000 claims description 7
- 238000001728 nano-filtration Methods 0.000 claims description 7
- 238000007670 refining Methods 0.000 claims description 7
- 238000000926 separation method Methods 0.000 claims description 7
- CHQMHPLRPQMAMX-UHFFFAOYSA-L sodium persulfate Substances [Na+].[Na+].[O-]S(=O)(=O)OOS([O-])(=O)=O CHQMHPLRPQMAMX-UHFFFAOYSA-L 0.000 claims description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 6
- 239000000356 contaminant Substances 0.000 claims description 6
- 238000000605 extraction Methods 0.000 claims description 6
- 235000011149 sulphuric acid Nutrition 0.000 claims description 6
- 239000001117 sulphuric acid Substances 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 5
- 238000004108 freeze drying Methods 0.000 claims description 4
- FVSKHRXBFJPNKK-UHFFFAOYSA-N propionitrile Chemical compound CCC#N FVSKHRXBFJPNKK-UHFFFAOYSA-N 0.000 claims description 4
- 238000005507 spraying Methods 0.000 claims description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 claims description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical class CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 3
- 238000004128 high performance liquid chromatography Methods 0.000 abstract description 11
- 238000011068 loading method Methods 0.000 abstract description 3
- 238000000746 purification Methods 0.000 abstract description 2
- HHLMIPMLRQMODA-UHFFFAOYSA-M [Na+].OP(O)(O)=O.OS([O-])(=O)=O Chemical compound [Na+].OP(O)(O)=O.OS([O-])(=O)=O HHLMIPMLRQMODA-UHFFFAOYSA-M 0.000 abstract 1
- 238000009776 industrial production Methods 0.000 abstract 1
- 239000008363 phosphate buffer Substances 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 239000012488 sample solution Substances 0.000 abstract 1
- XUKUURHRXDUEBC-SXOMAYOGSA-N (3s,5r)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid Chemical compound C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@H](O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-SXOMAYOGSA-N 0.000 description 11
- SBKRTALNRRAOJP-BWSIXKJUSA-N N-[(2S)-4-amino-1-[[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18R,21S)-6,9,18-tris(2-aminoethyl)-15-benzyl-3-[(1R)-1-hydroxyethyl]-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-6-methylheptanamide (6S)-N-[(2S)-4-amino-1-[[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18R,21S)-6,9,18-tris(2-aminoethyl)-15-benzyl-3-[(1R)-1-hydroxyethyl]-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-6-methyloctanamide sulfuric acid Polymers OS(O)(=O)=O.CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](CCN)NC1=O)[C@@H](C)O.CC[C@H](C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](CCN)NC1=O)[C@@H](C)O SBKRTALNRRAOJP-BWSIXKJUSA-N 0.000 description 6
- 229960003548 polymyxin b sulfate Drugs 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 238000013016 damping Methods 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000005374 membrane filtration Methods 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 241000194105 Paenibacillus polymyxa Species 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000002390 rotary evaporation Methods 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 101000748137 Homo sapiens Ubiquitin carboxyl-terminal hydrolase 31 Proteins 0.000 description 1
- 101000759988 Homo sapiens Ubiquitin carboxyl-terminal hydrolase 48 Proteins 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- 206010065764 Mucosal infection Diseases 0.000 description 1
- 108010040201 Polymyxins Proteins 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 102100025023 Ubiquitin carboxyl-terminal hydrolase 48 Human genes 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000003570 biosynthesizing effect Effects 0.000 description 1
- 229940126600 bulk drug product Drugs 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 238000004237 preparative chromatography Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
Landscapes
- Peptides Or Proteins (AREA)
Abstract
Description
多粘菌素 | R | R′ | X | 分子式 | Mr |
B1 | CH3 | CH3 | L-Leu | C56H98N16O13 | 1204 |
B2 | H | CH3 | L-Leu | C56H96N16O13 | 1190 |
B3 | CH3 | H | L-Leu | C56H96N16O13 | 1190 |
B1-I | CH3 | CH3 | L-Ile | C56H98N16O13 | 1204 |
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110390624.5A CN103130876B (zh) | 2011-11-30 | 2011-11-30 | 一种高纯度多粘菌素b的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110390624.5A CN103130876B (zh) | 2011-11-30 | 2011-11-30 | 一种高纯度多粘菌素b的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103130876A CN103130876A (zh) | 2013-06-05 |
CN103130876B true CN103130876B (zh) | 2014-07-23 |
Family
ID=48491373
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110390624.5A Expired - Fee Related CN103130876B (zh) | 2011-11-30 | 2011-11-30 | 一种高纯度多粘菌素b的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103130876B (zh) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102863518B (zh) * | 2012-10-09 | 2014-04-30 | 湖北美林药业有限公司 | 一种多粘菌素b化合物及其制备方法 |
KR102585108B1 (ko) | 2014-12-16 | 2023-10-05 | 상하이 미큐알엑스 파마슈티컬 컴퍼니 리미티드 | 세균 감염의 치료를 위한 항미생물성 폴리믹신 |
JP2019531338A (ja) * | 2016-08-19 | 2019-10-31 | 湖北瑞昊安科医薬科技発展有限公司 | ポリミキシンb1硫酸塩、ポリミキシンb2硫酸塩、又はこれらの混合物の結晶、及びその製造方法 |
CN107759670B (zh) * | 2016-08-19 | 2020-12-04 | 湖北瑞昊安科医药科技发展有限公司 | 硫酸多粘菌素b1、b2或其混合物的结晶及其制备方法 |
CN106868079B (zh) * | 2017-04-26 | 2020-12-08 | 山东鲁抗医药股份有限公司 | 发酵硫酸多粘菌素b用培养基及发酵生产硫酸多粘菌素b的方法 |
CN107367562B (zh) * | 2017-08-03 | 2020-03-24 | 上海上药第一生化药业有限公司 | 硫酸多黏菌素b的分析检测方法及应用 |
WO2021150792A1 (en) | 2020-01-21 | 2021-07-29 | Micurx Pharmaceuticals, Inc. | Novel compounds and composition for targeted therapy of kidney-associated cancers |
CN111410682A (zh) * | 2020-04-28 | 2020-07-14 | 梯尔希(南京)药物研发有限公司 | 多粘菌素b相关化合物的环化制备方法 |
CN116284254B (zh) * | 2023-02-28 | 2023-08-04 | 黄石曼菲特生物科技有限公司 | 一种从发酵液中提取高纯度高含量硫酸多粘菌素b单组分的方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010058427A3 (en) * | 2008-11-24 | 2010-09-10 | Reliance Life Sciences Pvt. Ltd. | Process for production and purification of polymyxin b sulfate |
CN101974075A (zh) * | 2010-10-12 | 2011-02-16 | 山东鲁抗医药股份有限公司 | 从发酵技术培养物中提取多粘菌素b、e的方法 |
-
2011
- 2011-11-30 CN CN201110390624.5A patent/CN103130876B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010058427A3 (en) * | 2008-11-24 | 2010-09-10 | Reliance Life Sciences Pvt. Ltd. | Process for production and purification of polymyxin b sulfate |
CN101974075A (zh) * | 2010-10-12 | 2011-02-16 | 山东鲁抗医药股份有限公司 | 从发酵技术培养物中提取多粘菌素b、e的方法 |
Non-Patent Citations (4)
Title |
---|
何凤云等.多粘菌素B中多粘菌素B_1的制备方法研究.《化工时刊》.2011,第25卷(第08期),20-22. |
响应面法优化多粘菌素B的发酵条件;田东 等;《中国农学通报》;20101231;第26卷(第15期);53-57 * |
多粘菌素B中多粘菌素B_1的制备方法研究;何凤云等;《化工时刊》;20110831;第25卷(第08期);20-22 * |
田东 等.响应面法优化多粘菌素B的发酵条件.《中国农学通报》.2010,第26卷(第15期),第53-57页. |
Also Published As
Publication number | Publication date |
---|---|
CN103130876A (zh) | 2013-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103130876B (zh) | 一种高纯度多粘菌素b的制备方法 | |
CN104817604B (zh) | 一种β‑烟酰胺单核苷酸的纯化方法 | |
EP3064214B1 (en) | Separation and purification method for vancomycin hydrochloride of high purity | |
CN102863519B (zh) | 一种盐酸万古霉素的精制方法 | |
CN105001309B (zh) | 一种达巴万星的分离纯化方法 | |
CN101418327A (zh) | 高纯度5’核苷酸的生产新工艺 | |
CA3100869A1 (en) | Method for preparing precursor of recombinant human insulin or analogue thereof | |
CN101386614B (zh) | 树脂吸附法制备表没食子儿茶素没食子酸酯的方法 | |
CN103242402B (zh) | 一种快速制备高纯度的n6-(2-羟乙基)腺苷的方法 | |
CN107929367B (zh) | 离子交换法从钩吻中分离制备钩吻生物碱的方法 | |
CN106831943B (zh) | 一种低成本纯化透皮肽的方法 | |
CN102145040A (zh) | 采用大孔树脂吸附提取肾茶有效部位的工艺方法 | |
CN105418631B (zh) | 一种用高效液相色谱分离纯化奈马菌素的方法 | |
CN104356140A (zh) | 一种高纯度莫西克汀的膜分离制备方法 | |
CN102659872B (zh) | 一种高纯度灯盏花乙素的制备方法 | |
CN101781367B (zh) | 一种来匹卢定的纯化方法 | |
CN103910783A (zh) | 一种高纯度棘白霉素b母核的制备方法 | |
CN100393691C (zh) | 一种采用大孔吸附树脂制备扁桃酸的方法 | |
CN106589075B (zh) | 一种替考拉宁的提纯方法 | |
CN102464635B (zh) | 一种牛蒡子苷元的分离纯化方法 | |
CN102967683A (zh) | 一种(3r)-叔丁基二甲硅氧基-5-氧代-6-三苯基膦烯己酸甲酯的高效液相色谱分析法 | |
CN102617727A (zh) | 一种胸腺法新化合物及其新制法 | |
CN1162433C (zh) | 一种纯化鲀毒素的方法 | |
CN117903296A (zh) | 一种非水体系分离纯化比伐芦定的方法 | |
CN105777777A (zh) | 西罗莫司的纯化方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: GUANGDONG EVERGREEN PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: TIANJIN HAIDE ANKE PHARMACEUTICAL TECHNOLOGY DEVELOPMENT CO., LTD. Effective date: 20131017 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 300457 BINHAI NEW DISTRICT, TIANJIN TO: 510000 GUANGZHOU, GUANGDONG PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20131017 Address after: 510000, building 16, building 108, Feng Wei building, right new road, Yuexiu District temple, Guangzhou,, Guangdong Applicant after: TIANJIN HAIDE ANKE MEDICAL TECHNOLOGY DEVELOPMENT CO., LTD. Address before: 300457 Tianjin international biological medicine joint research institute building, 220 Dongting Road, Tianjin Binhai New Area Development Zone, C407 Applicant before: Tianjin Haide Anke Medical Technology Development Co., Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170106 Address after: 430000 Hubei city of Wuhan province East Lake high tech Development Zone two No. 388 Wuhan Road, Optics Valley international biological pharmaceutical enterprise accelerator 20 building 3 layer Patentee after: HUBEI RUIHAO ANKE MEDICINE TECHNOLOGY DEVELOPMENT CO., LTD. Address before: Block A-B, building 16, Feng Wei building, No. 108 new road, Yuexiu District, Guangzhou, Guangdong Patentee before: TIANJIN HAIDE ANKE MEDICAL TECHNOLOGY DEVELOPMENT CO., LTD. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140723 Termination date: 20201130 |